A Study to Evaluate the Efficacy and Safety of BuMA Supreme Drug Eluting Stent(DES)

A trial with no phase registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 1000 participants.

Also called NCT02698852

  • Study
  • In this atlas

Overview

Design
Interventional study; allocation not applicable; no masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 1,000 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT02698852
Start date
(registry gives no type) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(anticipated) (from the registry)
Countries
China (from the registry)
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT02698852. Allocation not applicable; no masking; primary purpose treatment. Start 2015-12 (registry gives no type); primary completion 2019-05 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
A Study to Evaluate the Efficacy and Safety of BuMA Supreme Drug Eluting Stent(DES)
Acronym
OPC
Intervention (Device)
BuMA Supreme
Lead sponsor
Sino Medical Sciences Technology Inc. (class: industry)

Record details

Record id
cardio:ct-nct02698852
Content hash
a6e23397ba8332015c2eb9c7a1de833d3f45c8afdbcef9f5956b85b4fcbd1f3f